Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2020-04-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于聘任高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a senior management personnel (Assistant General Manager) by the company's board of directors. It includes details about the individual's background, qualifications, and compliance with regulatory requirements. The document is short (1202 characters) and focuses solely on management changes without financial data or other report content. Therefore, it fits the category of Board/Management Information (MANG).
2020-04-27 Chinese
关于2020年度预计担保额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the expected guarantee amount for the year 2020. It details the guarantee limits provided by the company to its subsidiaries, including financial data of the subsidiaries, guarantee terms, and approvals from the board and independent directors. The document does not contain comprehensive financial statements or detailed financial performance data typical of an Annual Report or Interim Report. It is not a call transcript, earnings release, or a report on legal proceedings. Instead, it is a regulatory announcement about financing-related guarantees and approvals. This fits best under Capital/Financing Update (CAP), as it relates to the company's financing activities and guarantees provided to subsidiaries within credit limits.
2020-04-27 Chinese
2020年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2020 年第一季度报告全文" which translates to "2020 First Quarter Report Full Text." It contains detailed financial data such as revenue, net profit, cash flow, shareholder information, and other financial metrics for the first quarter of 2020. The document includes comprehensive financial statements and analysis for a period shorter than a full fiscal year, specifically a quarter. It is not an announcement or a brief summary but a full quarterly report with substantive financial data. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2020
2020-04-27 Chinese
关于公司控股股东部分股份质押公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the company's controlling shareholder. It details the number of shares pledged, the proportion of total shares, pledge dates, and related information. There is no financial statement, earnings data, or management discussion. The document is short (1829 characters) and serves as a disclosure of a capital-related event (share pledge). This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share pledges.
2020-04-23 Chinese
关于公司实际控制人减持公司股份预披露公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding the planned reduction of shares held by the company's actual controller, including details about the number of shares, timing, methods of sale, and compliance with regulatory requirements. It does not contain financial statements, audit information, or detailed financial results. It is a regulatory disclosure about insider shareholding changes, specifically a planned share reduction by a major shareholder. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2020-04-07 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase (buyback) activities. It details the number of shares repurchased, prices, compliance with regulations, and timing of the repurchase. It does not contain financial statements or earnings data, nor is it a full report or presentation. The content matches the description of a 'Transaction in Own Shares' filing, which reports on share buyback activities.
2020-04-01 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.